Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis
Journal of Research in Health Sciences · 2023
DOI: 10.34172/jrhs.2023.128 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Research in Health Sciences, 2023. Verfasst von Shima Hossaini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, Randomized Controlled Trials as Topic, SARS-CoV-2. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
Different vaccines have so far been developed and approved to cope with COVID-19 in the world. The aim of this updated network meta-analysis (NMA) was to compare and rank all available vaccines in terms of efficacy and complications simultaneously. Study Design: A systematic review.
Methods
Three major international databases, including Web of Science, Medline via PubMed, and Scopus, were searched through September 2023. The transitivity assumption was evaluated qualitatively in terms of epidemiologic effect modifiers. The exposure of interest in this study was receiving any available COVID-19 vaccine, and the primary outcome of interest was the incidence of symptomatic COVID-19. In this NMA, the relative risk of symptomatic COVID-19 was used to summarize the efficacy of vaccines in preventing COVID-19. The data were analyzed using the frequentist-based approach, and the results were reported using a random-effects model. Finally, the vaccines were ranked using a P-score.
Results
In total, 34 randomized controlled trials (RCTs) met the eligibility criteria for this systematic review and NMA out of 3682 retrieved references. Based on the results of the NMA, mRNA-1273 was the most effective vaccine in preventing COVID-19 and demonstrated the highest P-score (0.93). The relative risk (RR) for mRNA-1273 versus placebo was 0.07 (95% confidence interval [CI]: 0.03, 0.17). The second and third-ranked vaccines were BNT-162b2 (RR=0.08; 95% CI: 0.04, 0.15; P-score=0.93) and Gam-COVID-Vac (0.09; 95% CI: 0.03, 0.25; 0.88).
Conclusion
Based on the results of this NMA, it seems that all available vaccines were effective in COVID-19 prevention. However, the top three ranked vaccines were mRNA-1273, BNT-162b2, and Gam-COVID-Vac, respectively.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, School of Public Health, Hamadan University of Medical Sciences, Hamadan, Iran.
- Department of Infectious Disease, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
- Modeling of Noncommunicable Diseases Research Center, Hamadan University of Medical Sciences, Hamedan, Iran.
- Research Center for Health Sciences, Hamadan University of Medical Sciences, Hamadan, Iran.
ORCID-Profile: Shima Hossaini, Amin Doosti-Irani
Zitieren
APA
Hossaini, S., Keramat, F., Cheraghi, Z., Zareie, B., & Doosti-Irani, A. (2023). Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis. Journal of Research in Health Sciences. https://doi.org/10.34172/jrhs.2023.128
Vancouver
Hossaini S, Keramat F, Cheraghi Z, Zareie B, Doosti-Irani A. Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis. Journal of Research in Health Sciences. 2023. doi:10.34172/jrhs.2023.128
BibTeX
@article{Hossaini2023,
author = {Hossaini, Shima and Keramat, Fariba and Cheraghi, Zahra and Zareie, Bushra and Doosti-Irani, Amin},
title = {Comparing the Efficacy and Adverse Events of Available COVID-19 Vaccines Through Randomized Controlled Trials: Updated Systematic Review and Network Meta-analysis},
journal = {Journal of Research in Health Sciences},
year = {2023},
doi = {10.34172/jrhs.2023.128}
}
EUVIMED